Stress-induced mutagenesis fuels the evolution of bacterial pathogens, resistance to antibiotics, tumor progression, and resistance to chemotherapy, all of which occur under stress and are driven by genetic changes (reviewed in references
1 and
2). Although initially controversial because of a lack of distinction between the stress conditions and the conditions used to select for the mutations, the idea that stress-induced mutagenesis induces a hypermutagenic state in subpopulations of bacterial cells is now widely accepted (
2). Several studies in
Escherichia coli and
Saccharomyces cerevisiae focused on genome alterations leading to adaptation in starving or aging cells (
3). Importantly, in subsequent starvation episodes, organisms carrying stress-induced genomic rearrangements exhibited a fitness advantage relative to the parental strain (
4).
Loss of heterozygosity (LOH) reveals genetic variability in diploid organisms by exposing the phenotypes associated with recessive alleles and often has detrimental outcomes for an organism. For example, LOH is a prerequisite for the initiation and the development of cancer (
5) via inactivation of tumor suppressor genes (two-hit hypothesis) (
6); indeed, LOH has been associated with breast (
7), skin (
8), and colorectal (
9) cancer. In addition, allele-specific gene expression or allelic imbalance plays a critical biological role in human variability (
10). Finally, increased recombination in response to stress (fitness-associated recombination [FAR] [
11,
12]) is thought to promote the evolution of complex traits by accelerating the rate of adaptation (
13).
LOH events may reveal genetic diversity that affects fitness under stress conditions and/or unstressed conditions. The extent of LOH can range from short LOH tracts that form via gene conversion or double crossovers to long LOH tracts which arise via a single crossover event or by nonreciprocal events such as break-induced replication (BIR), and generate a region of homozygosity extending from the site of recombination to the telomere.
Whole-chromosome (whole-Chr) LOH, a product of chromosome nondisjunction that most frequently occurs because of defects in centromere/kinetochore/mitotic spindle function, usually results in aneuploidy, an imbalance in the number of chromosomes. Most aneuploid strains grow less well than their euploid parental strain. However, under specific stress conditions such as extreme temperature, nutrient shortage, and exposure to chemotherapeutic (
14) or antifungal (
15–
17) drugs, some aneuploidies provide a strong fitness advantage. Strains monosomic for a specific chromosome often undergo reduplication of the remaining homolog, yielding a disomic, homozygous chromosome (
18). If the two alleles in the heterozygous parental strain provide a differential benefit under a given stress, cells that retain the more beneficial allele after LOH may exhibit a growth advantage over cells that do not undergo LOH.
Candida albicans is a commensal fungus that resides in the human oral cavity, the gastrointestinal tract, and the genitourinary tract. Within the host, it competes with other microbes for nutrition in different body niches and adapts to different temperatures, different pH ranges, and different levels of oxidative stress, for example, when it encounters immune cells such as phagocytes (for a review, see reference
19). Under conditions of weakened immunity or imbalance in the commensal flora,
C. albicans becomes an opportunistic pathogen with a disease spectrum ranging from mild superficial infections, such as oral thrush and vaginitis, to severe, life-threatening bloodstream infections such as disseminated candidiasis. These different candidal infections involve colonization of, and thus adaptation to, different host environmental niches and growth conditions, including elevated temperatures in the febrile host. Treatment with antifungal drugs is sometimes accompanied by the rapid acquisition of drug resistance, which can arise by chromosome rearrangements and/or chromosome missegregation (
15,
16).
How
C. albicans adapts to abrupt changes in environmental conditions is not well understood.
C. albicans is a highly heterozygous diploid that reproduces primarily via mitotic division (
20,
21). It possesses a mating locus (
MAT) (
22) and undergoes a parasexual cycle, in which diploids mate (
23,
24) to form tetraploids that subsequently undergo “concerted chromosome loss,” producing near-diploid progeny that are often trisomic and/or homozygous for one or more whole chromosomes. Multiple short-range recombination events occur within a subset of parasexual progeny, yielding recombinant chromosomes (
25,
26). Homothallic mating further enriches the repertoire of routes that
C. albicans can use to generate the wide range of genetic diversity observed in clinical isolates (
27–
29). Importantly, since no meiosis has been detected in
C. albicans, genetic diversity is assumed to arise only via mitotic events.
In
C. albicans, LOH events, as well as whole-Chr and segmental aneuploidies, have been observed in strains growing under selection for antifungal drug resistance (
15–
17). For example, homozygosis of hyperactive alleles of positive regulators of drug efflux pumps (
15,
30) or of genes encoding drug targets, such as
ERG11 (
31), or increased copy numbers of these genes provide a selective advantage in the presence of these drugs (
32). In contrast, growth on poor carbon or nitrogen sources sometimes selects for LOH due to loss of whole chromosomes or chromosome segments (
18,
33).
In
C. albicans, little is known about the frequency of genetic changes that arise spontaneously and whether the rate of appearance of those changes is affected by exposure to stress. Furthermore, rates of spontaneous LOH have been measured only at one genomic locus (
GAL1) (
34,
35). Since the types of events that arise at different loci are often influenced by local features of the DNA (e.g., proximity to direct or inverted repeats or transposons can lead to gross chromosomal rearrangements, chromosome aberrations, and overall genome instability in
S. cerevisiae [
36–
38]), it is important to determine both the rates and the types of LOH events that occur most frequently and to ask if there are chromosome regions with especially high or low rates of LOH in general. Furthermore, since candidal infections are treated with antifungal drugs and antifungal drug resistance can cause significant clinical complications, it is important to understand how
C. albicans cells respond to physiologically relevant stresses, including antifungal drug stress.
Here, we measured rates of LOH and the distribution of types of LOH events that appeared in the absence and in the presence of physiologically relevant stresses. Importantly, we found that stress affected the rates and types of LOH events in a manner that was proportional to the degree of stress. Thus, it appears that C. albicans generates increased genetic diversity in response to a range of stress conditions but that it employs more than one mechanism to do so.